Cita APA (7a ed.)
Hirlekar, R., Momin, A., & Bhairy, S. (2024). Formulation development, in-vitro and ex-vivo evaluation of dry adsorbed solid lipid nanoparticles: An approach of overcoming olanzapine drawbacks. European Pharmaceutical Journal, 71(1), 1-16.
Cita Chicago Style (17a ed.)
Hirlekar, Rajashree, Alfiha Momin, y Srinivas Bhairy. "Formulation Development, In-vitro and Ex-vivo Evaluation of Dry Adsorbed Solid Lipid Nanoparticles: An Approach of Overcoming Olanzapine Drawbacks." European Pharmaceutical Journal 71, no. 1 (2024): 1-16.
Cita MLA (9a ed.)
Hirlekar, Rajashree, et al. "Formulation Development, In-vitro and Ex-vivo Evaluation of Dry Adsorbed Solid Lipid Nanoparticles: An Approach of Overcoming Olanzapine Drawbacks." European Pharmaceutical Journal, vol. 71, no. 1, 2024, pp. 1-16.
Precaución: Estas citas no son 100% exactas.